Back
Best Practices for the Use of Direct Oral Anticoagulants in Obesity
Best Practices for the Use of Direct Oral Anticoagulants in Obesity
Episodes
All
All
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease
2
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
3
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
4
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
5